pharmaasiaJanuary 06, 2017
Tag: drug discovery , biologically active molecules
Dotmatics, a leading provider of scientific informatics solutions and services, has announced that Fundación MEDINA, a leading non-profit Research Organization, has implemented the Dotmatics’ Studies Notebook.
Dotmatics’ Studies Notebook Platform is providing MEDINA with a highly customized, nimble way of recording drug discovery, natural products chemistry, microbiological and general data in a compliant Electronic Laboratory Notebook (ELN).
The Dotmatics notebook creates a true collaborative environment where researchers can share ideas and discuss results in real time. Additional modules such as Register and Biology, can be implemented in order to enable scientists to cover the complete workflow. User-controlled security access across the entire platform ensures both the safekeeping of data as well as integrity.
"By providing MEDINA with a flexible and agile ELN that covers all scientific disciplines in a single interface, we are able to deliver the only truly web-based ELN that allows all entered fields to be fully searchable," said Stephen Gallagher PhD, CEO Dotmatics. "The combination of our technology with their research expertise holds great promise for the future of novel drug discovery.
"We needed to implement a system which would manage our experimentations and in terms of time, efficiency and drug discovery processes," said Dr. Olga Genilloud, Scientific director of MEDINA. "We evaluated several ELN vendors and after careful consideration, chose Dotmatics because they offered flexible and comprehensive solutions with extensive support. The Dotmatics´ notebook will provide our team with significant technological improvements."
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: